4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0001209191-23-037387
President and CEO sold 27,090 shares at $84.83 ($2,298,085)
- President and CEO acquired 27,090 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YEAMAN KEVIN J President and CEO | 2023-06-13 | Option exercise | +27,090 | $42.98 | $1,164,328 | 78,969 | I: show line 1 in the form |
| YEAMAN KEVIN J President and CEO | 2023-06-13 | Sale | −27,090 | $84.83 | $2,298,085 | 51,879 | I: show line 2 in the form |
| Open-market sales · 27,090 sh · avg $84.83 · $2,298,085 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YEAMAN KEVIN J President and CEO | 2023-06-13 | Option exercise · Employee Stock Option (Right to Buy) | −27,090 | 135,696 | I: show line 3 in the form |
Loading xslF345X04/doc4.xml…